Moshe Rogosnitzky
4PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Mar 15, 2022
Low-dose naltrexone, an opioid-receptor antagonist, is a broad-spectrum analgesic: a retrospective cohort study.Samuel J Martin, Heath B McAnally, Paul Okediji
|Mar 16, 2021
No Time to Waste: Real-World Repurposing of Generic Drugs as a Multifaceted Strategy Against COVID-19.Moshe Rogosnitzky, Esther Berkowitz, Alejandro R Jadad
|Jul 24, 2020
Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19.Moshe Rogosnitzky, Paul Okediji, Igor Koman
|May 07, 2020
Delivering Benefits at Speed Through Real-World Repurposing of Off-Patent Drugs: The COVID-19 Pandemic as a Case in Point.Moshe Rogosnitzky, Esther Berkowitz, Alejandro R Jadad
Pageof 1
